Ublituximab

Briumvi

Concentrato per soluzione per infusioneItalyAuthorised

In other countries

The same active substances on other registers, the same brand first.

BriumviBrazil · Neuraxpharm Brasil Importacao e Distribuicao de Medicamentos Ltda.Same brand
Briumvi 150 MG Concentrado Para Solucion Para PerfusionSpain · 150 mg · concentrado para solución para perfusión · Neuraxpharm Pharmaceuticals S.L.Same brand
BriumviEuropean Union · Neuraxpharm Pharmaceuticals S.L.Same brand
BriumviCroatiaSame brand
Briumvi 150 mg concentraat voor oplossing voor infusieNetherlands · Concentraat voor oplossing voor infusie · Neuraxpharm Pharmaceuticals S.L.Same brand
BriumviUnited States · 25 MG/ML · injectable · TG Therapeutics, INCSame brand

Packs

Pack	Code

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Ublituximab

Briumvi

Concentrato per soluzione per infusioneItalyAuthorised

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Packs

Pack	Code

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agenzia Italiana del Farmaco (AIFA), Italy

Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.

Licence: CC BY 4.0; AIFA published open-data catalog · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Ublituximab
Dosage form: Concentrato per soluzione per infusione
Register: Italy (AIFA)
Status: Authorised
Status in the register: Autorizzata
Registration: AIC 050698
Marketing authorisation holder: Neuraxpharm Pharmaceuticals, S.L
ATC code: L04AG14
Group: Antineoplastic and immunomodulating agents
Procedure: Procedura Centralizzata
Supply: Medicinali soggetti a prescrizione medica limitativa, utilizzabili esclusivamente in ambiente ospedaliero o in una struttura ad esso assimilabile

150 mg - Concentrato per soluzione per infusione - Uso endovenoso - Flaconcino (vetro) 6 ml (25 mg / ml) - 1 flaconcino	050698012	Autorizzata
150 mg - Concentrato per soluzione per infusione - Uso endovenoso - Flaconcino (vetro) 6 ml (25 mg / ml) - 3 flaconcini	050698024	Autorizzata